deltatrials
Terminated PHASE4 INTERVENTIONAL NCT01099592

Antidepressants to Promote Recovery of Cardiac Patients Suffering From Depression (ARCADE)

Predictors of Depression Treatment Response Following an Acute Coronary Syndrome

Sponsor: Canadian Institutes of Health Research (CIHR)

Conditions Acute Coronary Syndrome Major Depressive Episode
Interventions Citalopram
Updated 6 times since 2017 Last updated: Jan 27, 2016 Started: Nov 30, 2010 Primary completion: Apr 30, 2011 Completion: Apr 30, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

inability to recruit

Other terminated trials from Canadian Institutes of Health Research (CIHR)

See all terminations from Canadian Institutes of Health Research (CIHR)

Other Acute Coronary Syndrome trials with similar outcome

Browse all Acute Coronary Syndrome trials

Listed as NCT01099592, this PHASE4 trial focuses on Acute Coronary Syndrome and Major Depressive Episode and remains terminated or withdrawn. Sponsored by Canadian Institutes of Health Research (CIHR), it has been updated 6 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE4

  5. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE4

    First recorded

Nov 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Canadian Institutes of Health Research (CIHR)
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal
  • Centre hospitalier de l'Université de Montréal (CHUM)
  • Montreal Heart Institute
Data source: Centre hospitalier de l'Université de Montréal (CHUM)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations